Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice”

Affiliations

Xiao-Wen Chen: Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
Xiao-Yan Du: Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
Yu-Xian Wang: Department of Gerontology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
Jian-Cheng Wang: Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
Wen-Ting Liu: Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
Wen-Jing Chen: Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
Hong-Yu Li: Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
Fen-Fen Peng: Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
Zhao-Zhong Xu: Department of Emergency, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
Hong-Xin Niu: Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
Hai-Bo Long: Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China

Abstract

No abstracts available.